Latest Research Reports

Early detection of invasive breast cancer substandard in urban China

Early detection of invasive breast cancer substandard in urban China

US faces high, growing burden of CDI

US faces high, growing burden of CDI

Despite challenges, pain-related indications are most frequently researched clinical trials

Despite challenges, pain-related indications are most frequently researched clinical trials

Healthcare-related CDIs rivaled by community cases

Healthcare-related CDIs rivaled by community cases

Analyst forecasted growth of battling blockbusters, Keytruda and Opdivo

Analyst forecasted growth of battling blockbusters, Keytruda and Opdivo

AML therapeutics market expected to diversify by 2026

AML therapeutics market expected to diversify by 2026

Diagnosed incident cases of cystic fibrosis are set to decrease

Diagnosed incident cases of cystic fibrosis are set to decrease

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

EMA set to approve plethora of oncology drugs

EMA set to approve plethora of oncology drugs

The global burden of rheumatoid arthritis will increase

The global burden of rheumatoid arthritis will increase

US and UK stand out with higher disease prevalence of two autoimmune diseases

US and UK stand out with higher disease prevalence of two autoimmune diseases

The launch of long-acting therapies will drive the growth of the growth hormone deficiency Market

The launch of long-acting therapies will drive the growth of the growth hormone deficiency Market

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Anticipated approval timeline of PARP inhibitors in HER2-negative breast cancer

Anticipated approval timeline of PARP inhibitors in HER2-negative breast cancer

A look at atrial fibrillation’s market size forecast

A look at atrial fibrillation’s market size forecast

Will competitive US pricing be enough to give Valeant’s Siliq an edge?

Will competitive US pricing be enough to give Valeant’s Siliq an edge?

Eylea enables Regeneron to dominate the ocular market

Eylea enables Regeneron to dominate the ocular market

Dark clouds: the growing burden of major depressive disorder

Dark clouds: the growing burden of major depressive disorder

Biogen will retain the lion’s share of the neurology market

Biogen will retain the lion’s share of the neurology market

Seven kings of diabetes will remain in power for years to come

Seven kings of diabetes will remain in power for years to come

Surge in deals promises a brighter future for fatty liver disease

Deals involving drugs to treat fatty liver disease (FLD) hit an all-time high in 2016, with more than twice as many completed as in any year...

Surge in deals promises a brighter future for fatty liver disease